L Catterton related stories
All articles and analysis
L Catterton completes continuation fund for portfolio company PatientPointThe continuation fund's investors include Neuberger Berman and Fortress Investment Group.
L Catterton-backed beauty company Oddity debuts on the NASDAQOddity is the parent company of beauty and wellness brands IL Makiage and SpoiledChild.
Hunter Point Capital seeks firms poised for next phase of global expansionThe GP stakes and financing solutions platform is backing alternative asset managers across North America, Europe and Asia, CEO Avi Kalichstein tells PEI.
L Catterton taps Chang as managing partner and private credit co-headAlongside Shahab Rashid, Chang will co-lead the firm's direct lending strategy.
Synova sells stake to Bonaccord in pan-European pushBonaccord’s latest investment follows a recent strategic partnership with Singapore-based asset management firm Asia Heritage.
Lipstick effect: 6 PE-backed beauty and personal care dealsYellow Wood, Wind Point, L Catterton and TruArc Partners are some of the firms investing in the BPC sector.
Ex-L Catterton dealmaker’s shop Newcastle targets $200m for Fund INewcastle’s strategy draws on managing partner Chris Casgar’s experience at L Catterton and Webster Equity Partners, with a focus on investing in consumer products and services businesses.
Sustainability-linked carry edges towards the mainstreamLinking impact or ESG to financial incentives was a big topic at the Impact Investor Global Summit; it is an 'imperative for the industry' that requires investors and managers to adopt an experimental mindset.
Side Letter: Guy Hands' biggest worry; Norvester's haul; SERS Ohio's PE hikeMonday is a public holiday in the US and UK, so we'll return to your inboxes on Tuesday. In the meantime, Terra Firma's Guy Hands reveals his biggest investment concerns, and a Nordic GP is beating the fundraising blues. Here’s today's brief, for our valued subscribers only.
Wafra and Investcorp buy GP stake in UK-headquartered MML CapitalThe pair are taking equal stakes in the mid-market-focused investment firm in a Houlihan Lokey-advised transaction.